For example, Zhang et al. [12] found that DLGAP5 was remarkably upregulated in ovarian cancer and its higher expression was correlated with poorer prognosis for survival, while the inhibition of DLGAP5 resulted in suppressed cell proliferation, G2/M phase arrest and apoptosis induction in ovarian cancer [12]. This evidence concerns the gene DLGAP5 and ovarian cancer.